IDYA — Ideaya Biosciences Inc · rev $15.4M

Ideaya Biosciences Inc (IDYA) is a biotechnology company listed on NASDAQ.

Latest reported IDYA revenue for 2026-06-30 was $15.4M. Net income was -$211.0M. IDYA currently screens at market cap $2.96B.

Use this IDYA page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the IDYA quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the IDYA SEC filings page. Lician reads the product cache first so this HTML stays unique to Ideaya Biosciences Inc even when a live quote feed is slow.

Ideaya Biosciences Inc latest statements (FY2025)

Latest cached year on this hub. Full IDYA income, balance, and cash tables.

  • Revenue$218.7M
  • Net Income-$113.7M
  • Total Assets$1.11B
  • Total Debt$0
  • Free Cash Flow-$73.5M

IDYA recent filings